Can You Read These Rxs?

Published Online: Monday, August 4, 2014

Rx 1

Pharm Tech Dhaval H. Patel at Walgreens in Bloomington, Illinois, was perplexed by this prescription.
Can you figure it out?

Rx 2 After Steve King, RPh, was presented with this puzzler at Snider Drugs, Inc, in Bloomfield, Kentucky, further investigation was required to determine the prescriber’s intention.
Can you read this Rx?

Rx 3
Paige Killingsworth, RPh, PharmD, at Realo Discount Drugs in Trenton, North Carolina, was able to decipher the first half of this prescription, but the second half required a call to the prescriber.
Can you read the prescription?

Rx 4
Lori Van Devender, PharmD, at McDaniel Pharmacy in Port Gibson, Minnesota, had no idea what this prescription called for, except that it was for a sick child.
Do you know what it says? CAN YOU READ THESE RXS?
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to kmckay@pharmacytimes .com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 666 Plainsboro Road, Suite 300, Plainsboro, NJ 08536.

Latest Articles
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Latest Issues